Stockscreener 앱 받기
1.59
1.24%
-0.02
시간 외 거래:
1.59
전일 마감가:
$1.61
열려 있는:
$1.6
하루 거래량:
45,751
Relative Volume:
0.41
시가총액:
$15.57M
수익:
$52.16M
순이익/손실:
$-48.60M
주가수익비율:
-0.3681
EPS:
-4.32
순현금흐름:
$-77.48M
1주 성능:
+5.30%
1개월 성능:
+89.29%
6개월 성능:
-36.90%
1년 성능:
-78.85%
1일 변동 폭
$1.51
$1.61
1주일 범위
$1.48
$1.62
52주 변동 폭
$0.721
$9.09
Hookipa Pharma Inc Stock (HOOK) Company Profile
명칭
Hookipa Pharma Inc
전화
0114318906360
주소
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY
HOOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
1.59 | 18.41M | 52.16M | -48.60M | -77.48M | -4.32 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-15 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-12-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-11-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-08 | 개시 | Morgan Stanley | Overweight |
| 2020-11-03 | 개시 | Truist | Buy |
| 2020-10-26 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-19 | 재개 | H.C. Wainwright | Buy |
| 2019-09-27 | 개시 | H.C. Wainwright | Buy |
| 2019-05-13 | 개시 | BofA/Merrill | Buy |
| 2019-05-13 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Hookipa Pharma Inc 주식(HOOK)의 최신 뉴스
Gilead (GILD) to Acquire HOOK for $10 million - MSN
Gilead Sciences to Acquire HOOKIPA Pharma Assets for $10M - GuruFocus
Hookipa Pharma (NASDAQ:HOOK) Trading Up 6.6% – Time to Buy? - Defense World
HOOKIPA to Sell HBV, HIV Program Assets to Gilead; Shares Rise - marketscreener.com
Hookipa stock gains as Gilead eyes assets (HOOK:NASDAQ) - Seeking Alpha
Poolbeg Pharma plc (AIM:POLB) Increase of BookBuild Offer - Share Talk
HOOKIPA Pharma Inc expected to post a loss of $1.04 a shareEarnings Preview - TradingView
The Significance of Moving Averages in Hookipa Pharma Inc Inc. (HOOK) Price Performance - investchronicle.com
Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Update - Defense World
Short Interest in Hookipa Pharma Inc (NASDAQ:HOOK) Drops By 75.2% - The AM Reporter
Hookipa Pharma stock hits 52-week low at $0.81 amid sharp decline - Investing.com India
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline By Investing.com - Investing.com South Africa
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India
Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday - Defense World
HOOKIPA Pharma to participate in upcoming investor conferences in September - marketscreener.com
Hookipa Pharma (HOOK) Expected to Announce Earnings on Thursday - Defense World
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline - Investing.com Australia
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline By Investing.com - Investing.com South Africa
HOOKIPA Pharma Inc. SEC 10-K Report - TradingView
Hookipa Pharma stock hits 52-week low at $1.56 amid downturn - Investing.com India
Hookipa Pharma stock hits 52-week low at $1.56 amid downturn By Investing.com - Investing.com South Africa
Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know - MSN
BRIEF—Proposed combination of Poolbeg with HOOKIPA called off - The Pharma Letter
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia
Poolbeg slumps as Hookipa merger is called off - pharmaphorum
Hookipa Pharma (NASDAQ:HOOK) Shares Down 4.8% – Time to Sell? - Defense World
Poolbeg Pharma PLC (AIM:POLB) Termination of proposed combination with HOOKIPA - Share Talk
Poolbeg merger off after HOOKIPA ends discussions - Proactive Investors
Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger - TradingView
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewswire
HOOKIPA Pharma ends talks to acquire Poolbeg Pharma - Investing.com India
Failed Merger: Why HOOKIPA Pharma Walked Away from Poolbeg Deal - StockTitan
Hookipa Pharma stock hits 52-week low at $1.71 amid downturn - MSN
Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial - Yahoo Finance
Hookipa Pharma Files Petition to Validate Stockholder Actions at Annual Meetings - Defense World
HOOKIPA completes enrollment for HIV vaccine trial By Investing.com - Investing.com Nigeria
HOOKIPA Pharma seeks court validation for stockholder actions By Investing.com - Investing.com Australia
HOOKIPA completes enrollment for HIV vaccine trial - Investing.com India
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b - GlobeNewswire
Game-Changing HIV Vaccine Trial Fully Enrolled: HOOKIPA's Path to Potential Cure - StockTitan
Hookipa Pharma Inc (HOOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.89%
3.74%
자본화:
|
볼륨(24시간):